Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.68 BRL | +18.74% |
|
+6.91% | +25.94% |
Jul. 09 | RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating | MT |
Jul. 03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Bio Therapeutic Drugs | +18.74% | +6.91% | +25.94% | +77.49% | - | 14.74B | - | - | - |
- Stock Market
- Equities
- NBIX Stock
- N1BI34 Stock
- Charts Neurocrine Biosciences, Inc.
- Relative Strength Chart